Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;98(26):e16084.
doi: 10.1097/MD.0000000000016084.

Can heme oxygenase-1 be a prognostic factor in patients with hepatocellular carcinoma?

Affiliations

Can heme oxygenase-1 be a prognostic factor in patients with hepatocellular carcinoma?

Cheon-Soo Park et al. Medicine (Baltimore). 2019 Jun.

Abstract

Heme oxygenase-1 (HO-1) is an important catalytic enzyme in heme degradation, which increases during stressful conditions. It plays a major role in antioxidative and antiapoptotic processes and is associated with tumor growth and metastasis.This study aimed to evaluate the degree of HO-1 expressions in hepatocellular carcinoma (HCC) surgical specimens and the correlation between HO-1 expression and patient prognosis. Formalin-fixed, paraffin-embedded HCC tissue samples (n = 96) were included in the analysis, and the expression of HO-1 was evaluated by immunohistochemical staining. We reviewed clinical features of patients and evaluated the prognostic role of HO-1 in patient survival and recurrence.Positive HO-1 expression was identified in 43 cases (44.8%) and was frequently found in patients with advanced histology (Edmondson-Steiner [E-S] grade 2, 3, 4), α-fetoprotein (AFP) level of more than 200 IU/mL, and the presence of microvascular and capsular invasion (P < .05). In the univariate analysis, the overall survival (OS) and disease-free survival (DFS) of patients with HO-1-positive HCC were not statistically different from those with HO-1-negative HCC. Moreover, HO-1 expression was not associated with patient survival and recurrence based on the multivariate analysis. In the subgroup analysis of patients without preoperative transarterial chemoembolization (TACE) (n = 61), HO-1 was not also associated with tumor recurrence (P = .681).The clinical implication of HO-1 activity is controversial in various malignancies. However, HO-1 expression did not seem to influence the prognosis of HCC patients.

PubMed Disclaimer

Conflict of interest statement

There is no potential conflict of interest relevant to this article.

Figures

Figure 1
Figure 1
Schematic illustration of the heme oxygenase pathway. CO = carbon monoxide, Fe2+ = ferrous ion, UV = ultraviolet.
Figure 2
Figure 2
The hepatocellular carcinoma cells (A, H&E 200×) were diffusely positive for heme oxygenase-1 (B, IHC 200×). On the other hand, hepatocellular carcinoma cells (C, H&E 200×) were negative for heme oxygenase-1 expression (D, IHC 200×).
Figure 3
Figure 3
Kaplan–Meier analysis of hepatocellular carcinoma recurrence (n = 96). HO-1 = heme oxygenase-1.
Figure 4
Figure 4
Kaplan-Meier analysis of hepatocellular carcinoma recurrence in the non-TACE group (n = 61). HO-1 = heme oxygenase-1, TACE = transarterial chemoembolization.

References

    1. Minagawa M, Makuuchi M, Takayama T, et al. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 2003;238:703–10. - PMC - PubMed
    1. Imamura H, Matsuyama Y, Tanaka E, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003;38:200–7. - PubMed
    1. Schoemaker MH, Ros JE, Homan M, et al. Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis. J Hepatol 2002;36:742–50. - PubMed
    1. Yamaguchi Y, Shiraki K, Fuke H, et al. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death. Oncol Rep 2005;14:1311–6. - PubMed
    1. Sass G, Leukel P, Schmitz V, et al. Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice. Int J Cancer 2008;123:1269–77. - PubMed

MeSH terms